Board of Directors


Martin Mellish

Independent Non-Executive Chairman

Martin Mellish has served as founding director of Aspen Advisory Services Ltd., a London-based private office overseeing private and listed investments in North America, Europe, and Asia, since 1994. Mr. Mellish serves as a non-executive director of NuCana plc (Nasdaq: NCNA; member, Audit Committee), Levitronix Technologies Inc. (Chair, Audit Committee), Alturki Holding (Chair, Audit Committee), Saudi Readymix Concrete Company, (Chair, Audit Committee), Kensington Green (Management) Limited (Chair, Estates Environment & Security Committee) and Omnicyte Limited. Probono he is a member of the International Advisory Council of the Massachusetts General Hospital, a former trustee of the London Academy for Music and Dramatic Arts (LAMDA) and former Treasurer to the Council of the Chapels Royal at HM Tower of London.

From 1984 to 1992 he was Financial Controller and Chief Financial Officer of Alturki Holding, an industrial investment company based in Saudi Arabia with offices in North America and Asia. Mr. Mellish trained at Price Waterhouse and was registered as a Certified Public Accountant (Mass.) in 1983. He holds an SM (Management) from the Massachusetts Institute of Technology, Boston, USA, an M.Sc. (Accounting) from Northeastern University, Boston, USA, and an A.B. (Political Science) from Amherst College, Amherst, Mass., USA.

Mr. Mellish is a 2022 degree candidate in the Master of Health Care Delivery Science programme at Dartmouth College, Hanover NH, USA.


Wensheng Fan

Chief Executive Officer

Wensheng Fan is an executive, entrepreneur and innovator with over 20 years of experience in natural speech recognition, imaging systems, medical devices and artificial intelligence. Currently, Mr. Fan builds and leads the team the team to transform DeepView® for burn and chronic wound imaging applications from concept and prototype to an FDA 510(k) cleared product.

Prior to joining Spectral, Mr. Fan was a Global Vision Application Engineering Manager for Sensata Technologies (former Texas Instruments Sensors & Controls Division) with a focus on introducing imaging sensor and vision systems into automotive original equipment manufacturers for auto safety features. He was also an Engineering Manager at Philips, where he specialised in integrating natural speech recognition into the telecommunication world. Mr. Fan holds six patents on image processing and natural speech recognition algorithms and applications and was the founder and/or early core member for three successful start-up companies.

Mr. Fan received his MSEE degree from Northeastern University in Boston, MA and BSEE degree from Tsinghua University in Beijing, China.


Erich Spangenberg

Non-Executive Director

Erich Spangenberg is a serial entrepreneur and industry luminary in the patent business. Mr. Spangenberg is the Chief Executive Officer and founder of Ipwe, a company which uses blockchain and artificial intelligence to create the intellectual property asset class. Mr. Spangenberg founded nXn Partners, a company that is focused on predictive analytics. He was also the founder and Chief Executive Officer of IPNav, a pioneer and leader in patent monetisation, and a company that generated over half a billion dollars in licensing, settlement, or enforcement revenues for its clients. 

Mr. Spangenberg is a former investment banker (having held positions at Donaldson, Lufkin, and Jenrette) and corporate lawyer (working for Jones Day). From investment banking he joined the corporate world, where he was the president of Smartalk Teleservices and Acclaim Ventures Group. 

Mr. Spangenberg was a Periclean Scholar at Skidmore College, a Distinguished Graduate in his Master’s degree program at The London School of Economics, and was on Law Review at Case Western Reserve University, where he earned his JD.


Richard Cotton

Independent Non-Executive Director

Richard Cotton has a wealth of experience in senior financial roles in life sciences and other sectors, including broadcast and photographic, automotive, filtration and metals. His experience covers all financial management and value creation activities from R&D, to manufacturing and commercial in international organisations. He has significant experience in the development and successful execution of strategy, corporate finance and M&A, capital markets and governance.

Mr. Cotton was Chief Financial Officer of FTSE250 animal health company Dechra Pharmaceuticals plc, and prior to that Chief Financial Officer of medical device and drug formulation business Consort Medical plc. He was also Finance Director of Vitec Group plc, Group Finance Director at Wagon plc and Group Finance Director of McLeod Russel plc. Prior to this he held senior finance roles in Alcoa Inc. 

Fellow of the Chartered Institute of Management Accountants, Mr Cotton holds a BA (Hons) in Business Studies from Kingston University.


Cynthia Cai

Independent Non-Executive Director

Dr. Cynthia Cai is an investor targeting early-stage opportunities of innovation and disruptive technology. Prior to that, Dr. Cai had over 25 years of experience in sales, marketing and business development in the healthcare and life science industry, and has held leadership positions with Agilent Technologies, where she was responsible for its billion-dollar Chromatography, automation and Mass Spec. business. Previously, Dr. Cai was involved in multiple acquisitions and divestitures, and led a US$500+ million-dollar flagship instrument development and its global commercialisation. Dr. Cai earned a B.A. and Master of Engineering from Tsinghua University, and received her Ph.D. in Chemistry from the University of Massachusetts and MBA from The Wharton Business School of the University of Pennsylvania. Dr. Cai has also served as Delaware governor economic advisor, and a member of the Board of the Forum for Executive Women (FEW-DE). Dr. Cai has been a regular speaker at healthcare conferences such as BIO; RESI; China Focus at J.P. Morgan, SAPA Annual Conference and Wharton China Business Forum.

Gerry Beaney

Independent Non-Executive Director

Gerry Beaney is currently a consultant to growth companies seeking strategic advice or funding for expansion. He has carried out senior executive roles in the corporate finance sector for over 25 years. During 2018, he was the Chief Executive Officer of Northland Capital Partners Limited, an institutional stockbroker based in London, and prior to this acted as Northland’s Head of Corporate Finance between 2014 and 2018. From 1997 to 2013, Mr Beaney was a Partner and Head of Capital Markets at Grant Thornton UK LLP which grew to become the largest independent nominated adviser to AIM companies under his leadership.

Prior to 1997, Mr Beaney held various roles with Grant Thornton in the UK and New York City. He is a member of the Institute of Chartered Accountants of Scotland, and was a member of the American Institute of Certified Public Accountants between 1991 and 2016. He holds a Bachelor of Accountancy Degree from the University of Glasgow.